Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $121.46M in the quarter ending March 31, 2025, with 61.95% growth. This brings the company's revenue in the last twelve months to $432.16M, up 72.16% year-over-year. In the year 2024, Axsome Therapeutics had annual revenue of $385.69M with 42.53% growth.

• Revenue (ttm): $432.16M
• Revenue Growth: +72.16%
• P/S Ratio: 11.50
• Revenue / Employee: $632,734
• Employees: 683
• Market Cap: 5.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.